2014 International Meeting on the Molecular Biology of Hepatitis B Viruses

项目摘要 该提案要求提供资金，以支持年轻科学家的差旅费， 参加并参加2014年B型肝炎分子生物学国际会议 病毒，定于2014年9月3日至6日在大学的会议设施， 加州，洛杉矶。这次会议是唯一一个聚集国际社会 研究人员的重点是肝炎B病毒（HBV）和密切相关的肝炎 delta病毒（HDV）。世界上大约有25%的人口感染了HBV。 不幸的是，尽管预防性疫苗的可用性，许多新的感染发生 在世界范围内，这主要是因为由于成本和其他问题导致疫苗利用不足。 此外，对于已经慢性感染HBV的约3.5亿人来说， （其中约有1500万人同时感染HDV），该疫苗没有治疗作用。 值因此，全世界每年有50万至100万人死于HBV/HDV。是 因此，HBV的基础研究必须继续下去，该领域的最新进展是 及时进行讨论和传播。年度HBV会议提供了论坛 科学交流和最新研究信息的传播。2014年会议 将坚持和加强传统的格式。它将包括9个口头科学会议和2个 海报会议以及结构不太合理的“网络”时间。科学的互动将是 通过两次主旨发言进行了推动。与过去一样，已经做出了很大的努力，以尽量减少 会议的费用。此外，B型肝炎基金会作出了坚定的承诺， 自2005年以来，我一直支持这次会议，为组织这次会议提供一个永久的场所。 会议，并安排其工作人员组织会议和宣传会议，特别是 有大量少数民族代表不足的大学。以便允许 初级和少数民族研究人员的参与，NIH的支持，以帮助支付会议费用 费用要求。

Project Summary This proposal is a request for funding to support the travel expenses for young scientists to attend and participate in the 2014 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 3 - 6, 2014 at the conference facility of the University of California, Los Angeles. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2014 meeting will uphold and enhance the traditional format. It will consist of 9 oral scientific sessions and 2 poster sessions as well as less structured "networking" time. The scientific interactions will be facilitated by two keynote addresses. As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for organizing the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested.